Posts

Posted on

Independent directors will integrate half of Lleida.net’s board

PR Newswire

MADRID, Nov. 13, 2020 /PRNewswire/ — Mr. Jorge Sainz de Vicuña was appointed today an independent director of Lleida.net (BME:LLN) (EPA:ALLLN) (OTCQX:LLEIF), at the recommendation of the CEO and founder of the company, Sisco Sapena.

With this appointment, half of Lleida.net board of directors is now formed by independent directors.

Until yesterday, Mr. Sainz de Vicuña held the position in the company as a proprietary director, representing the group of shareholders made up by Cántabro Catalana de Inversiones S.A., Empresa Nacional de Innovación (ENISA) and Sepi Desarrollo Empresarial (SEPIDES).

He resigned at the request of those funds, after having expired the pooling agreement for 21.27% of the shares which allowed his appointment.

Sainz de Vicuña’s appointment, which has been ratified by the Board of Directors, is recognition to his work in favor of the company.

“Jorge has been an important board member since Lleida.net started to trade in Paris and New York. His opinion is important for the company, and we are delighted that he will continue as a member of the board of directors”, explained Sapena, who founded the company in 1995. Previously, Jorge Sainz de Vicuña, was a proprietary director of Lleida.net between 2018 and 2020, in representation several reference shareholders.

He worked in Banco Santander, in management functions, and previously in Banco Español de Crédito and in Banesto’s Corporación Industrial y Financiera.

He has more than 25 years of experience in managing companies belonging to their respective industrial portfolios and to venture capital funds. 

He has carried out tasks in the fields of M&A, strategy, operations and financial restructuring in companies of various sectors and sizes.

He was CEO of Depósitos Portuarios and Galaxia Televisión, and a board member of the World Trade Center Barcelona, Advent España, Laparanza and Oildor, among others.

He has a degree in Economics, and Business Studies from the Colegio Universitario de Estudios Financieros (CUNEF) and a PDG from IESE.

Lleida.net is currently the leading European company in the eSignature industry.

Its services of notification and electronic contracting are recognized as valid before courts and public administrations in more than 75 countries.

The company has 187 patents in digital signature matters, which have been granted by more than 50 countries in the five continents, including the United States, the European Union, China, Russia, India, Mexico, Japan, Colombia, Argentina, Peru, South Africa, Nigeria, Australia or New Zealand.

Lleida.net started trading in the OTCQX Best Markets index in New York last week.

Contact:
The Paloma Project
Media, [email protected]  
+356-7946-7486

Cision View original content:http://www.prnewswire.com/news-releases/independent-directors-will-integrate-half-of-lleidanets-board-301172977.html

SOURCE Lleida.net

Posted on

Vertex Recommends Rejection of ‘Mini-Tender’ Offer From TRC Capital Investment Corporation

Vertex Recommends Rejection of ‘Mini-Tender’ Offer From TRC Capital Investment Corporation

BOSTON–(BUSINESS WIRE)–Vertex Pharmaceuticals Incorporated (Nasdaq:VRTX) today announced that it has been notified of an unsolicited “mini-tender” offer dated November 9, 2020, made by TRC Capital Investment Corporation, an Ontario, Canada, corporation to purchase up to 1,000,000 shares of Vertex common stock. TRC Capital’s unsolicited “mini-tender” offer price of $210.00 per share is approximately 4.67% below the $220.28 per share closing price of Vertex’s common stock on November 6, 2020, the last trading day prior to the commencement of the offer.

Vertex does not endorse TRC Capital’s offer and recommends that Vertex shareholders reject the offer and not tender their shares in response to TRC Capital’s unsolicited offer. The “mini-tender” offer is at a price below the market price of shares of Vertex’s common stock (as of today’s date) and is subject to numerous conditions, including TRC Capital’s ability to obtain financing necessary to consummate the offer. Vertex is not affiliated in any way with TRC Capital, the offer, or the offer documentation.

TRC Capital has made many similar “mini-tender” offers for the shares of other companies. “Mini-tender” offers are designed to seek less than five percent of a company’s outstanding shares, thereby avoiding many disclosure and procedural requirements of the U.S. Securities and Exchange Commission (SEC) because they are below the SEC’s threshold to provide such disclosure and procedural protections for investors.

The SEC has cautioned investors about “mini-tender” offers in an investor alert. The SEC noted that these offers “have been increasingly used to catch investors off guard” and that many investors who hear about “mini-tender” offers “surrender their securities without investigating the offer, assuming that the price offered includes the premium usually present in larger, traditional tender offers.”

To read more about the risks of “mini-tender” offers, please review the alert on the SEC’s website at http://www.sec.gov/investor/pubs/minitend.htm.

Like TRC Capital’s other offers, this “mini-tender” puts individual investors at risk because they may sell their shares at a discount without so realizing. Vertex urges shareholders to obtain current stock quotes for their shares of Vertex common stock, review the terms and conditions to the offer, consult with their broker or financial adviser and exercise caution with respect to TRC Capital’s “mini-tender” offer. Shareholders who have already tendered should consider the advisability of withdrawing their shares as permitted under TRC Capital’s Offer to Purchase documents.

Shareholders who have already tendered their shares may withdraw them at any time prior to the expiration of the offer, and if TRC Capital has not accepted a shareholder’s shares for payment pursuant to the offer, that shareholder may withdraw them at any time after December 21, 2020, until TRC Capital accepts the shareholder’s shares for payment, in accordance with TRC Capital’s offering documents.. According to the offer documents, the offer is currently scheduled to expire at 12:01 a.m., New York City time, on December 9, 2020.

Vertex encourages broker-dealers, as well as other market participants, to review the SEC’s letter regarding broker-dealer “mini-tender” offer dissemination and disclosure at https://www.sec.gov/divisions/marketreg/minitenders/sia072401.htm and the NASD Notice to Members regarding guidance to members forwarding “mini-tender” offers to their customers, which can be found at https://www.finra.org/sites/default/files/NoticeDocument/p004221.pdf.

Vertex requests that a copy of this news release be included with all distributions of materials relating to TRC Capital’s “mini-tender” offer related to shares of Vertex’s common stock.

About Vertex

Vertex is a global biotechnology company that invests in scientific innovation to create transformative medicines for people with serious diseases. The company has multiple approved medicines that treat the underlying cause of cystic fibrosis (CF) — a rare, life-threatening genetic disease — and has several ongoing clinical and research programs in CF. Beyond CF, Vertex has a robust pipeline of investigational small molecule medicines in other serious diseases where it has deep insight into causal human biology, including pain, alpha-1 antitrypsin deficiency and APOL1-mediated kidney diseases. In addition, Vertex has a rapidly expanding pipeline of genetic and cell therapies for diseases such as sickle cell disease, beta thalassemia, Duchenne muscular dystrophy and type 1 diabetes mellitus.

Founded in 1989 in Cambridge, Mass., Vertex’s global headquarters is now located in Boston’s Innovation District and its international headquarters is in London. Additionally, the company has research and development sites and commercial offices in North America, Europe, Australia and Latin America. Vertex is consistently recognized as one of the industry’s top places to work, including 11 consecutive years on Science magazine’s Top Employers list and a best place to work for LGBTQ equality by the Human Rights Campaign. For company updates and to learn more about Vertex’s history of innovation, visit www.vrtx.com or follow us on Facebook, Twitter, LinkedIn, YouTube and Instagram.

(VRTX-GEN)

Vertex Pharmaceuticals Incorporated

Investors:

[email protected]

or

617-961-7163

Media:

[email protected]

or

U.S.: 617-341-6992

or

International: +44 20 3204 5275

KEYWORDS: Massachusetts United States North America

INDUSTRY KEYWORDS: Health Diabetes Genetics Pharmaceutical Cardiology Biotechnology

MEDIA:

Logo
Logo
Posted on

Taat Producing 600 lb / 272 kg of Beyond Tobacco™ Per Day, Increased Capacity from Upgraded Equipment can Provide Material for up to 2.1 Million Taat Cartons Per Year

After beginning large-scale in-house production of Taat’s Beyond Tobacco™ base material, the Company has already reached 50% of its production capacity even before launching. Each 16-hour day of production yields approximately 600 lb / 272 kg of Beyond Tobacco™, which is sufficient to produce one full 1,440-carton pallet of Taat. Based on current volumes, the Company has procured new machinery to be installed in its Las Vegas, NV processing facility which is expected to increase production bandwidth to as much as
2,400 lb / 1,088 kg per day
. Additionally, the Company’s CEO Setti Coscarella has released an informational video statement in which Mr. Coscarella details the weaknesses of mainstream alternatives to tobacco cigarettes, and explains how Taat is being developed and commercialized to address these shortcomings.

LAS VEGAS and VANCOUVER, British Columbia, Nov. 13, 2020 (GLOBE NEWSWIRE) — TAAT LIFESTYLE & WELLNESS LTD. (CSE: TAAT) (OTCQB: TOBAF) (FRANKFURT: 2TP2) (the “Company” or “Taat”) is pleased to announce that its in-house production of the Beyond Tobacco™ base material for Taat, its flagship product to be launched in Ohio later this month, is now being produced at a rate of approximately 600 lb / 272 kg per day, a quantity that is sufficient to produce approximately one full 1,440-carton pallet of Taat. As stated in the Company’s press release dated October 16, 2020, Taat’s Las Vegas, NV processing facility can produce up to 1,200 lb / 544 kg of Beyond Tobacco™ per day. Having already reached 50% of its in-house production capacity for Beyond Tobacco™ even before launching Taat, the Company has ordered upgraded machinery to accommodate forecasted increases in demand following the debut of Taat in the United States. In addition to current interest in Taat from tobacco wholesalers and retailers in Ohio, nearly one third of unique visitors to the Company’s TryTaat landing page (http://trytaat.com) have requested Taat product samples. With Taat’s Ohio launch set to occur later this quarter, the Company’s Las Vegas, NV processing facility has been in operation for 16 hours per day every day including weekends to prepare a sufficient supply of Beyond Tobacco™ to meet anticipated demand.

The Company has developed Beyond Tobacco™ to taste, smell, and burn similarly to tobacco, despite containing no tobacco or nicotine. Beyond Tobacco™ is the base material of Taat, an alternative to traditional cigarettes offered in a cigarette-style format in Original, Smooth, and Menthol varieties. Under executive leadership with “Big Tobacco” pedigree, the Company has chosen the state of Ohio as the launch market for Taat in the United States, where an initial supply of Taat intended for sale at retail will arrive in Ohio later in Q4 2020. The Beyond Tobacco™ base material is processed in the Company’s Las Vegas, NV facility with a 14-step refinement procedure. Finished Beyond Tobacco™ is then sent to the Company’s contract manufacturer, who also makes cigarettes for national and global brands, for production and warehousing before shipment to wholesalers.

Beginning in mid-November 2020, deliveries of upgraded machinery for producing Beyond Tobacco™ will begin to arrive at the Company’s Las Vegas, NV processing facility. The new equipment, which includes conveyor belts and a vacuum sealer, is expected to increase Taat’s daily production capacity of Beyond Tobacco™ to a maximum of 2,400 lb / 1,088 kg per 16-hour day. Based on current Taat manufacturing yields, the Company anticipates this greater production bandwidth for Beyond Tobacco™ will allow for more than 2.1 million ten-pack cartons of Taat to be made on an annual basis. At this time, the Company is continuing to produce approximately 600 lb / 272 kg of Beyond Tobacco™ per day until it establishes a supply of material sufficient to produce approximately 30 pallets (43,200 cartons) of Taat.

Taat Herb Co. Founder Joe Deighan in front of the Company’s facility in Las Vegas, NV, where the Beyond Tobacco™ base material is produced.

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/50fd3780-4d57-4233-b1dc-c67e5816af08

Readers using news aggregation services may be unable to view the media above. Please access the

Investor Relations

section of the Company’s website for a version of this press release containing all published media.

The Company is also pleased to release an informational video statement made by its Chief Executive Officer Setti Coscarella, in which Mr. Coscarella details the weaknesses of mainstream products positioned as alternatives to tobacco cigarettes, and explains how Taat has been developed to address such weaknesses. Based on positive feedback from investors and the general public regarding Taat’s proprietary video content, the Company intends to continue releasing informational videos from its management team and advisory board on its YouTube channel.

Taat CEO Setti Coscarella in the Company’s latest informational video statement, which can be viewed by clicking the thumbnail above or


clicking here


.

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/ed733b4e-968a-46b3-8fe1-eaf7e74cb200

Readers using news aggregation services may be unable to view the media above. Please access the

Investor Relations

section of the Company’s website for a version of this press release containing all published media.

Taat Herb Co. Founder Joe Deighan, who directly oversees the Company’s Las Vegas, NV processing facility operations, said “It’s very exciting to be playing a firsthand role in developments such as these as we bring the Taat vision to reality on such a large scale. As intense as it may be to lead non-stop production of Beyond Tobacco™ for 16 hours per day every day, this is a major turning point in our journey to launch. We already have the market-ready product formulation, the distribution reach, and the go-to-market plan. What we need now is inventory to meet anticipated demand, and the fact that the supply we’re producing today has a clear path to being placed on retail shelves among incumbent tobacco products soundly validates that we are now far past the initial R&D phase and well into the ‘doing business’ phase.”

Taat Chief Executive Officer Setti Coscarella commented, “With the amount of interest Taat has been getting from tobacco wholesalers and individual adult smokers from around the world, as well as thousands of free sample requests in the United States on our TryTaat landing page, it is no secret at all that quantity is now the name of the game in order to meet potential demand. This comes as no surprise considering how rapidly Taat sold out during early-stage retail market testing earlier this year. Accordingly, we have taken it upon ourselves to maximize output of Beyond Tobacco™ from our Las Vegas processing facility by operating two daily shifts instead of one, and upgrading our equipment to improve our production capacity. As I mentioned in the latest informational video, Taat is very unique in that it offers exactly what other alternatives to tobacco cigarettes cannot offer. Even before we’ve launched, smokers of legal age all across the United States have recognized this, which is why we are seeking to maximize our production capacity now. I look forward to seeing the performance of our upgraded equipment as we ramp up production of Beyond Tobacco™ to prepare for our launch in Ohio.”

On behalf of the Board of Directors of the Company,

TAAT LIFESTYLE & WELLNESS LTD.

“Setti Coscarella”

Setti Coscarella, CEO

For further information, please contact:

Taat Investor Relations
1-833-TAAT-USA (1-833-822-8872)
[email protected]

THE CANADIAN SECURITIES EXCHANGE (CSE) HAS NOT REVIEWED AND DOES NOT ACCEPT RESPONSIBILITY FOR THE ACCURACY OR ADEQUACY OF THIS RELEASE.

About Taat Lifestyle & Wellness Ltd.

The Company has developed Taat, which is a tobacco-free and nicotine-free alternative to traditional cigarettes offered in “Original”, “Smooth”, and “Menthol” varieties. Taat’s base material is Beyond Tobacco™, a proprietary blend which undergoes a patent-pending refinement technique causing its scent and taste to resemble tobacco. Under executive leadership with “Big Tobacco” pedigree, Taat is launching in the United States in Q4 2020 as the Company seeks to position itself in the $814 billion1 global tobacco industry.

For more information, please visit http://taatusa.com.

References

1

British American Tobacco – The Global Market

Forward Looking Statements

This news release contains “forward-looking information” within the meaning of applicable Canadian securities legislation. Often, but not always, forward-looking information and information can be identified by the use of words such as “plans”, “expects” or “does not expect”, “is expected”, “estimates”, “intends”, “anticipates” or “does not anticipate”, or “believes”, or variations of such words and phrases or state that certain actions, events or results “may”, “could”, “would”, “might” or “will” be taken, occur, or be achieved. Forward-looking information in this news release includes statements regarding the potential launch of Beyond Tobacco™, in addition to the following: Potential outcomes from planned upgrades to Taat’s production facility equipment. The forward-looking information reflects management’s current expectations based on information currently available and are subject to a number of risks and uncertainties that may cause outcomes to differ materially from those discussed in the forward-looking information. Although the Company believes that the assumptions and factors used in preparing the forward-looking information are reasonable, undue reliance should not be placed on such information and no assurance can be given that such events will occur in the disclosed timeframes or at all. Factors that could cause actual results or events to differ materially from current expectations include: (i) adverse market conditions; (ii) changes to the growth and size of the tobacco markets; and (iii) other factors beyond the control of the Company. The Company operates in a rapidly evolving environment. New risk factors emerge from time to time, and it is impossible for the Company’s management to predict all risk factors, nor can the Company assess the impact of all factors on Company’s business or the extent to which any factor, or combination of factors, may cause actual results to differ from those contained in any forward-looking information. The forward-looking information included in this news release are made as of the date of this news release and the Company expressly disclaims any intention or obligation to update or revise any forward-looking information whether as a result of new information, future events or otherwise, except as required by applicable law.

The statements in this news release have not been evaluated by Health Canada or the U.S. Food and Drug Administration. As each individual is different, the benefits, if any, of taking the Company’s products will vary from person to person. No claims or guarantees can be made as to the effects of the Company’s products on an individual’s health and well-being. The Company’s products are not intended to diagnose, treat, cure, or prevent any disease.

This news release may contain trademarked names of third-party entities (or their respective offerings with trademarked names) typically in reference to (i) relationships had by the Company with such third-party entities as referred to in this release and/or (ii) client/vendor/service provider parties whose relationship with the Company is/are referred to in this release. All rights to such trademarks are reserved by their respective owners or licensees.

Statement Regarding Third-Party Investor Relations Firms

Disclosures relating to investor relations firms retained by Taat Lifestyle & Wellness Ltd. can be found under the Company’s profile on http://sedar.com.



Posted on

Bespoke Capital Acquisition Corp. Reports Third Quarter 2020 Financial Results

Canada NewsWire

/NOT FOR DISTRIBUTION TO U.S. NEWSWIRES OR DISSEMINATION IN THE UNITED STATES/

TORONTO, Nov. 13, 2020 /CNW/ – Bespoke Capital Acquisition Corp. (TSX: BC.U) (TSX: BC.WT.U) (“BCAC“) is reporting its financial results for the interim period ending September 30, 2020. BCAC’s unaudited interim financial statements have been filed on the System for Electronic Document Analysis and Retrieval (“SEDAR“) and may be viewed by shareholders and interested parties under BCAC’s profile on SEDAR at www.sedar.com.

About Bespoke Capital Acquisition Corp.
Bespoke Capital Acquisition Corp. is a special purpose acquisition corporation incorporated under the laws of the Province of British Columbia for the purpose of effecting, directly or indirectly, a qualifying acquisition within a specified period of time.

SOURCE Bespoke Capital Acquisition Corp.

Posted on

Amgen To Present At The Jefferies Virtual London Healthcare Conference

PR Newswire

THOUSAND OAKS, Calif., Nov. 13, 2020 /PRNewswire/ — Amgen (NASDAQ:AMGN) will present at the Jefferies Virtual London Healthcare Conference at 12:00 p.m. ET on Wednesday, Nov. 18, 2020. Peter H. Griffith, executive vice president and chief financial officer at Amgen will present at the conference. Live audio of the presentation can be accessed from the Events Calendar on Amgen’s website, www.amgen.com, under Investors. A replay of the webcast will also be available on Amgen’s website for at least 90 days following the event.

About Amgen
 

Amgen is committed to unlocking the potential of biology for patients suffering from serious illnesses by discovering, developing, manufacturing and delivering innovative human therapeutics. This approach begins by using tools like advanced human genetics to unravel the complexities of disease and understand the fundamentals of human biology.  

Amgen focuses on areas of high unmet medical need and leverages its expertise to strive for solutions that improve health outcomes and dramatically improve people’s lives. A biotechnology pioneer since 1980, Amgen has grown to be one of the world’s leading independent biotechnology companies, has reached millions of patients around the world and is developing a pipeline of medicines with breakaway potential.  

For more information, visit www.amgen.com and follow us on www.twitter.com/amgen.  

CONTACT: Amgen, Thousand Oaks 
Megan Fox, 805-447-1423 (media)
Trish Rowland, 805-447-5631(media) 
Arvind Sood, 805-447-1060 (investors) 

 

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/amgen-to-present-at-the-jefferies-virtual-london-healthcare-conference-301172939.html

SOURCE Amgen

Posted on

QEBR to Refocus on Medical CBD

PR Newswire

NEW YORK, Nov. 13, 2020 /PRNewswire/ — Virtual Medical International Inc. (OTC: QEBR) today announced that it is returning to its medical roots by entering the Medical Grade CBD oil business.

“The majority shareholder has determined that it is in the best interest of all of the shareholders to repurpose the company’s strategy to take advantage of the important medical needs of millions of adults across the globe for which this product has the proven capability to relieve needless suffering,” reported Jun Liang, Board Member.

As a result of this change of business, Larry Eastland has resigned as CEO.  A new CEO will be announced shortly.

This will also result in QEBR exiting the Crypto currency hosting business which has proven to be a challenging and costly business for QEBR.

About QEBR:
QEBR is the trading symbol for Virtual Medical International, Inc., a Nevada corporation.

Forward-Looking Statements
Legal Notice Regarding Forward-Looking Statements in this news release that are not historical facts are forward-looking statements that are subject to risks and uncertainties. Forward-looking statements are based on current facts and analyses and other information that are based on forecasts of future results, estimates of amounts not yet determined, and assumptions of management. Forward looking statements are generally, but not always, identified by the words “expects”, “plans”, “anticipates”, “believes”, “intends”, “estimates”, “projects”, “aims”, “potential”, “goal”, “objective”, “prospective”, and similar expressions or that events or conditions “will”, “would”, “may”, “can”, “could” or “should” occur.

Actual results may differ materially from those currently anticipated due to a number of factors beyond the reasonable control of the Company. It is important to note that actual outcomes and the Company’s actual results could differ materially from those in such forward-looking statements. Factors that could cause actual results to differ materially include misinterpretation of data, the Company’s ability to raise financing for operations, breach by parties with whom we have contracted, and the possible inability to maintain qualified employees or consultant

For more information please see our website: http://www.qebr.net
Contact: [email protected]
Source: Jun Liang, QEBR Chief Technology Officer

Cision View original content:http://www.prnewswire.com/news-releases/qebr-to-refocus-on-medical-cbd-301172965.html

SOURCE QEBR

Posted on

BABA CLASS ACTION NOTICE: Glancy Prongay & Murray LLP Files Securities Fraud Lawsuit Against Alibaba Group Holding Limited

BABA CLASS ACTION NOTICE: Glancy Prongay & Murray LLP Files Securities Fraud Lawsuit Against Alibaba Group Holding Limited

LOS ANGELES–(BUSINESS WIRE)–Glancy Prongay & Murray LLP (“GPM”), announces that it has filed a class action lawsuit in the United States District Court for the Southern District of New York captioned Ciccarello v. Alibaba Group Holding Limited, et al., (Case No. 1:20-cv-09568) onbehalf of persons and entities that purchased or otherwise acquired Alibaba Group Holding Limited (“Alibaba” or the “Company”) (NYSE: BABA) securities between October 21, 2020 and November 3, 2020, inclusive (the “Class Period”). Plaintiff pursues claims under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 (the “Exchange Act”).

Investors are hereby notified that they have 60 days from the date of this notice to move the Court to serve as lead plaintiff in this action.

If you suffered a loss on your Alibaba investments or would like to inquire about potentially pursuing claims to recover your loss under the federal securities laws, you can submit your contact information at https://www.glancylaw.com/cases/alibaba-group-holding-limited/. You can also contact Charles H. Linehan, of GPM at 310-201-9150, Toll-Free at 888-773-9224, or via email at [email protected] or visit our website at www.glancylaw.com to learn more about your rights.

Alibaba is an online and mobile commerce company. Alibaba owns a 33% equity interest in Ant Small and Micro Financial Services Group Co., Ltd. (“Ant Group”), a financial technology company that is best known for operating Alipay, one of the largest mobile and online payments platforms.

On July 20, 2020, Ant Group announced that it had begun the process of a concurrent initial public offering (“IPO”) on the Shanghai and Hong Kong stock exchanges.

On October 26, 2020, Ant Group priced its IPO and was set to raise $34.5 billion, making it the largest public offering in history.

On November 2, 2020, Financial Times reported that Chinese regulators had met with Ant Group’s controller Jack Ma, executive chairman Eric Jing, Chief Executive Officer Simon Hu. The article stated that, though regulators did not provide details, “the Chinese word used to describe the interview – yuetan – generally indicates a dressing down by authorities.” The article also included a statement from Ant Group that it will “implement the meeting opinions in depth.”

On November 3, 2020, the IPO was suspended because Ant Group “may not meet listing qualifications or disclosure requirements due to material matters” related to the meeting with regulators the previous day and “the recent changes in the Fintech regulatory environment.”

On this news, the Company’s share price fell $25.27, or 8%, to close at $285.57 per share on November 3, 2020, on unusually heavy trading volume.

The complaint filed in this class action alleges that throughout the Class Period, Defendants made materially false and/or misleading statements, as well as failed to disclose material adverse facts about the Company’s business, operations, and prospects. Specifically, Defendants failed to disclose to investors: (1) that Ant Group did not meet listing qualifications or disclosure requirements for certain material matters; (2) that certain impending changes in the Fintech regulatory environment would impact Ant Group’s business; (3) that, as a result of the foregoing, Ant Group’s IPO was reasonably likely to be suspended; and (4) that, as a result of the foregoing, Defendants’ positive statements about the Company’s business, operations, and prospects were materially misleading and/or lacked a reasonable basis.

Follow us for updates on LinkedIn, Twitter, or Facebook.

If you purchased or otherwise acquired Alibaba’s securities during the Class Period, you may move the Court no later than 60 days from the date of this notice toask the Court to appoint you as lead plaintiff. To be a member of the Class you need not take any action at this time; you may retain counsel of your choice or take no action and remain an absent member of the Class. If you wish to learn more about this action, or if you have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Charles Linehan, Esquire, of GPM, 1925 Century Park East, Suite 2100, Los Angeles California 90067 at 310-201-9150, Toll-Free at 888-773-9224, by email to [email protected], or visit our website at www.glancylaw.com. If you inquire by email please include your mailing address, telephone number and number of shares purchased.  

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

Glancy Prongay & Murray LLP, Los Angeles

Charles H. Linehan, 310-201-9150 or 888-773-9224

1925 Century Park East, Suite 2100

Los Angeles, CA 90067

www.glancylaw.com

[email protected]

KEYWORDS: United States North America California

INDUSTRY KEYWORDS: Legal Professional Services

MEDIA:

Logo
Logo
Posted on

Maiden Holdings, Ltd. Releases Third Quarter 2020 Earnings

Maiden Holdings, Ltd. Releases Third Quarter 2020 Earnings

HAMILTON, Bermuda–(BUSINESS WIRE)–
Maiden Holdings, Ltd. (NASDAQ:MHLD) has released its third quarter 2020 financial results via its investor relations website at https://www.maiden.bm/investor_relations.

About Maiden Holdings, Ltd.

Maiden Holdings, Ltd. is a Bermuda-based holding company formed in 2007.

Sard Verbinnen & Co.

[email protected]

KEYWORDS: Bermuda Caribbean

INDUSTRY KEYWORDS: Professional Services Insurance Finance

MEDIA:

Posted on

Palo Alto Networks Positioned as a Leader in Gartner Magic Quadrant for Network Firewalls for the Ninth Consecutive Time

Positioned as Both Furthest in Completeness of Vision and Highest in Ability to Execute

PR Newswire

SANTA CLARA, Calif., Nov. 13, 2020 /PRNewswire/ — Palo Alto Networks (NYSE: PANW), the global cybersecurity leader, today announced that the company has been positioned in the Leaders quadrant of the Magic Quadrant® for Network Firewalls report by Gartner Inc. It was positioned furthest to the right for completeness of vision and highest for ability to execute among the 17 vendors evaluated. This marks the ninth consecutive time that Palo Alto Networks has been named a Leader in the report.

The Magic Quadrant for Network Firewalls evaluates vendors’ ability to execute as well as the completeness of their vision. Palo Alto Networks’ continuing commitment to innovation and customer success has again helped the company earn the Leader position.

“We’re honored that Gartner has recognized us as a Leader in nine consecutive Gartner Magic Quadrant for Network Firewalls reports,” said Anand Oswal, senior vice president and general manager at Palo Alto Networks. “We have continued to innovate over the past year to deliver a unique approach to cybersecurity. With the industry’s first ML-Powered Next-Generation Firewall and the 70+ new capabilities in PAN-OS 10.0 that we recently introduced, we leverage machine learning to proactively stop unknown threats, secure IoT devices and reduce errors with automatic policy recommendations.”

To learn more about the Palo Alto Networks Next-Generation Firewall platform, visit:
https://www.paloaltonetworks.com/products/secure-the-network/next-generation-firewall

To learn more about Palo Alto Networks’ recognition in the 2020 Gartner Magic Quadrant for Network Firewalls, please visit:
https://blog.paloaltonetworks.com/2020/11/netsec-gartner-magic-quadrant-leader-2020/

To read a complimentary copy of the 2020 Gartner Magic Quadrant for Network Firewalls, please visit:
https://start.paloaltonetworks.com/2020-gartner-mq-for-firewalls.html?utm_medium=pr&sfdcid=7014u000001Z8CVAA0 

Gartner Disclaimer

Gartner does not endorse any vendor, product or service depicted in its research publications, and does not advise technology users to select only those vendors with the highest ratings or other designation. Gartner research publications consist of the opinions of Gartner’s research organization and should not be construed as statements of fact. Gartner disclaims all warranties, expressed or implied, with respect to this research, including any warranties of merchantability or fitness for a particular purpose.

About Palo Alto Networks

Palo Alto Networks, the global cybersecurity leader, is shaping the cloud-centric future with technology that is transforming the way people and organizations operate. Our mission is to be the cybersecurity partner of choice, protecting our digital way of life. We help address the world’s greatest security challenges with continuous innovation that seizes the latest breakthroughs in artificial intelligence, analytics, automation, and orchestration. By delivering an integrated platform and empowering a growing ecosystem of partners, we are at the forefront of protecting tens of thousands of organizations across clouds, networks, and mobile devices. Our vision is a world where each day is safer and more secure than the one before. For more information, visit www.paloaltonetworks.com.

Palo Alto Networks and the Palo Alto Networks logo are trademarks of Palo Alto Networks, Inc. in the United States and jurisdictions throughout the world. All other trademarks, trade names, or service marks used or mentioned herein belong to their respective owners.

 

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/palo-alto-networks-positioned-as-a-leader-in-gartner-magic-quadrant-for-network-firewalls-for-the-ninth-consecutive-time-301172975.html

SOURCE Palo Alto Networks, Inc.

Posted on

Freddie Mac Prices $1.1 Billion Multifamily K-Deal, K-740

MCLEAN, Va., Nov. 13, 2020 (GLOBE NEWSWIRE) — Freddie Mac (OTCQB: FMCC) recently priced a new offering of Structured Pass-Through Certificates (K Certificates), which are backed by underlying collateral consisting of fixed-rate multifamily mortgages with predominantly 7-year terms. The company expects to issue approximately $1.1 billion in K-740 Certificates, which are expected to settle on or about November 20, 2020.

K-
740
Pricing

Class Principal/Notional
Amount (mm) 		Weighted
Average Life
(Years) 		Spread
(bps) 		Coupon Yield Dollar Price
A-1 $59.300 4.11 S+17 0.5940% 0.5858% $99.9965
A-2 $990.091 6.80 S+31 1.4700% 1.0009% $102.9980
A-M $139.811 6.92 S+36 1.0700% 1.0626% $99.9938
X1 $1,049.391 6.40 T+155 0.7612% 2.1146% $4.5831
XAM $139.811 6.67 T+135 1.1117% 1.9480% $7.0655
X3 $96.423 6.68 T+350 2.4817% 4.0989% $14.5083

Details

  • Co-Lead Managers and Joint Bookrunners: Credit Suisse Securities (USA) LLC and Wells Fargo Securities, LLC
  • Co-Managers: BMO Capital Markets Corp., BofA Securities, Inc., J.P. Morgan Securities LLC and Multi-Bank Securities, Inc.
  • Rating Agencies: Moody’s Investors Service, Inc. and Kroll Bond Rating Agency, LLC

Related Links

The K-740 Certificates are backed by corresponding classes issued by the FREMF 2020-K740 Mortgage Trust (K-740 Trust) and guaranteed by Freddie Mac. The K-740 Trust will also issue certificates consisting of Class X2-A, Class X2-B, Class D and Class R Certificates, which will not be guaranteed by Freddie Mac and will not back any class of K-740 Certificates.

Freddie Mac Multifamily is a leading issuer of agency-guaranteed structured multifamily securities. K-Deals are part of the company’s business strategy to transfer a portion of the risk of losses away from taxpayers and to private investors who purchase the unguaranteed subordinate bonds. K Certificates typically feature a wide range of investor options with stable cash flows and structured credit enhancement.

This announcement is not an offer to sell any Freddie Mac securities. Offers for any given security are made only through applicable offering circulars and related supplements, which incorporate Freddie Mac’s Annual Report on Form 10-K for the year ended December 31, 2019, filed with the Securities and Exchange Commission (SEC) on February 13, 2020; all other reports Freddie Mac filed with the SEC pursuant to Section 13(a) of the Securities Exchange Act of 1934 (Exchange Act) since December 31, 2019, excluding any information “furnished” to the SEC on Form 8-K; and all documents that Freddie Mac files with the SEC pursuant to Sections 13(a), 13(c) or 14 of the Exchange Act, excluding any information “furnished” to the SEC on Form 8-K.

Freddie Mac’s press releases sometimes contain forward-looking statements. Forward-looking statements involve known and unknown risks and uncertainties, some of which are beyond the company’s control. Management’s expectations for the company’s future necessarily involve a number of assumptions, judgments and estimates, and various factors could cause actual results to differ materially from the expectations expressed in these and other forward-looking statements. These assumptions, judgments, estimates and factors are discussed in the company’s Annual Report on Form 10-K for the year ended December 31, 2019, and its reports on Form 10-Q and Form 8-K, which are available on the Investor Relations page of the company’s Web site at www.FreddieMac.com/investors and the SEC’s website at www.sec.gov. The company undertakes no obligation to update forward-looking statements it makes to reflect events or circumstances occurring after the date of this press release. The multifamily investors section of the company’s Web site at https://mf.freddiemac.com/investors/ will also be updated, from time to time, with any information on material developments or other events that may be important to investors, and we encourage investors to access this website on a regular basis for such updated information.

The financial and other information contained in the documents that may be accessed on this page speaks only as of the date of those documents. The information could be out of date and no longer accurate. Freddie Mac undertakes no obligation, and disclaims any duty, to update any of the information in those documents.

Freddie Mac makes home possible for millions of families and individuals by providing mortgage capital to lenders. Since our creation by Congress in 1970, we’ve made housing more accessible and affordable for homebuyers and renters in communities nationwide. We are building a better housing finance system for homebuyers, renters, lenders, and taxpayers. Learn more at FreddieMac.com, Twitter @FreddieMac and Freddie Mac’s blog FreddieMac.com/blog.

MEDIA CONTACT:
Mike Morosi

703
–
918-5851

Michael_Morosi
@FreddieMac.com

INVESTOR CONTACT
S
:
Robert Koontz

571-382-4082

Amanda
Nunnink

312
–
407-7510